ECP for Angina
ECP for Angina
After completion of treatment, there was a significant decrease in severity of angina class (p <0.001), and 72% improved from severe angina to no angina or mild angina. Fifty-two percent of patients discontinued nitroglycerin use. Quality of life improved substantially. At 2 years this decrease in angina was maintained in 55% of patients. The 2-year survival rate was 83%, and the major adverse cardiovascular event-free survival rate was 70%.
Operation Environment
Ambient temperature: 10°C~30°C;
Relative humidity: less than 85%;
Atmospheric pressure (absolute pressure): 70kPa~106kPa;
Well ventilated and free of dust, corrosive gases and strong electromagnetic interference.
Products Feature
Products Feature
Forty-three percent had no reported cardiac hospitalization; 81% had no reported congestive heart failure events. Repeat EECP/ECP was performed in 20% of these patients. The only significant independent predictor of repeat EECP/ECP in a proportional hazard model was failure to complete the first EECP treatment course (hazard ratio 2.9, 95% confidence interval 1.7 to 4.9). Improvements in angina symptoms and quality of life were maintained at 2 years.
Subscribe Haider Group of Companies to Get Newest Update
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.